Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Research
Bristol-Myers Squibb is a pharmaceutical company dedicated to the research, development, and commercialization of treatments for a wide array of medical conditions. Its primary therapeutic domains include cardiovascular health, oncology, and immunological disorders. A significant strategic emphasis for the firm is immuno-oncology, an area where it has established itself as a leading innovator in developing new drugs. The company generates approximately 70% of its total revenue from the United States, indicating a considerably higher reliance on the American market compared to many of its industry counterparts.
Market snapshot
- Symbol
- BMYMP
- Price
- $400
- Day change
- -57.46%
- Market cap
- $110.3B
- P/E ratio
- 15.17x
- 52-week range
- 400-1050
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
Peer companies
Recent insider activity
- Haller Julia A — M-Exempt (20460 shares) on 2026-06-15
- Haller Julia A — M-Exempt (20460 shares) on 2026-06-15
- Short Bartie Wendy — M-Exempt (8040 shares) on 2026-06-03
- Short Bartie Wendy — F-InKind (3876 shares) on 2026-06-03
- Short Bartie Wendy — M-Exempt (8040 shares) on 2026-06-03
Open Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.